EUVIMEDEUVIMED entdecken
Open Access · CC BY 3.0

Neurotoxicity Caused by the Treatment with Platinum Analogues

Sousana Amptoulach, Nicolas Tsavaris

Chemotherapy Research and Practice · 2011

DOI: 10.1155/2011/843019 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Chemotherapy Research and Practice, 2011. Verfasst von Sousana Amptoulach und 1 weiteren Autor:innen. Beteiligte Einrichtung: Oncology Unit, Department of Pathophysiology, Laikon General Hospital, Athens University School of Medicine, 11527 Athens, Greece. Die Arbeit wurde bisher 63-mal zitiert (Crossref) und nennt 63 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 3.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Platinum agents (cisplatin, carboplatin, and oxaliplatin) are a class of chemotherapy agents that have a broad spectrum of activity against several solid tumors. Toxicity to the peripheral nervous system is the major dose-limiting toxicity of at least some of the platinum drugs of clinical interest. Among the platinum compounds in clinical use, cisplatin is the most neurotoxic, inducing mainly sensory neuropathy of the upper and lower extremities. Carboplatin is generally considered to be less neurotoxic than cisplatin, but it is associated with a higher risk of neurological dysfunction if administered at high dose or in combination with agents considered to be neurotoxic. Oxaliplatin induces two types of peripheral neuropathy, acute and chronic. The incidence of oxaliplatin-induced neuropathy is related to various risk factors such as treatment schedule, cumulative dose, and time of infusion. To date, several neuroprotective agents including thiol compounds, vitamin E, various anticonvulsants, calcium-magnesium infusions, and other nonpharmacological strategies have been tested for their ability to prevent platinum-induced neurotoxicity with controversial results. Further studies on the prevention and treatment of neurotoxicity of platinum analogues are warranted.

Autor:innen und Institutionen

  • Oncology Unit, Department of Pathophysiology, Laikon General Hospital, Athens University School of Medicine, 11527 Athens, Greece.

Zitieren

APA

Amptoulach, S., & Tsavaris, N. (2011). Neurotoxicity Caused by the Treatment with Platinum Analogues. Chemotherapy Research and Practice. https://doi.org/10.1155/2011/843019

Vancouver

Amptoulach S, Tsavaris N. Neurotoxicity Caused by the Treatment with Platinum Analogues. Chemotherapy Research and Practice. 2011. doi:10.1155/2011/843019

BibTeX
@article{Amptoulach2011,
  author = {Amptoulach, Sousana and Tsavaris, Nicolas},
  title = {Neurotoxicity Caused by the Treatment with Platinum Analogues},
  journal = {Chemotherapy Research and Practice},
  year = {2011},
  doi = {10.1155/2011/843019}
}
Kostenlos starten →